达利雷生能有效治病吗？

Introduction: DaliRasen is a dual orexin receptor antagonist (DORA), which acts as a selective dual antagonist of orexin receptors OX1 and OX2 and is used to treat insomnia. Dalirasin acts on the orexin receptors OX1R and OX2R, blocking the binding of orexin, which is an awakening-promoting neuropeptide and the endogenous ligand of these receptors. Dalirasin can reduce hyperactive arousal.

Can the generic version of DaliRasen be effective in treating diseases?

As of now, we have not learned that the generic version has been officially launched in China, so it is impossible to know whether the generic version of DaliRasen can effectively treat diseases. According to the results of clinical research conducted by Simcere Pharmaceuticals in collaboration with Swiss company Idorsia, DaliRasen has shown good effectiveness and safety in the treatment of insomnia.

When it comes to generic drugs, they are copies of the original drug and are designed to provide the same therapeutic benefits as the original drug. But the quality and effectiveness of generic drugs can vary depending on the manufacturer and production process. When considering generic medicines, it is important to ensure that they are made by a reputable manufacturer and have passed a quality review by the relevant regulatory agency.

In China, DaliRasen was jointly developed by Simcere Pharmaceuticals and Idorsia, and has been accepted by the National Medical Products Administration. If you are considering using DaliRasen or its generic version, it is recommended to seek the advice of a doctor or medical professional and ensure that the medicine comes from a reliable source to ensure safety and effectiveness.

The price of DaliRasen

The specification of DaliRasen produced by Idorsia Ltd/Switzerland Alschwil Company is 50mg*20 tablets/box. It is currently known that the price of a box is about 2955$-3600$. It is not fixed. This price may change due to exchange rate fluctuations, import taxes, freight and other factors. Please refer to the actual selling price for the specific price.

In addition, DaliRasen is not yet on the market in mainland China. When purchasing, you should ensure that you purchase the drug through legal and compliant channels.

Special population use of Dalilaysan

1. Children: The therapeutic effect of Dalilayson in children has not yet been determined, so it should be used with caution or not used.

2. Elderly patients: For elderly patients over 65 years old, there is usually no need to adjust the dose of Dalirasin. However, Dalirasin will increase the degree of drowsiness and drowsiness. Elderly patients have a higher risk of falling after taking this drug.

3. Patients with hepatic impairment: The use of DaliRasen in patients with hepatic impairment requires special caution. Not recommended for patients with severe hepatic impairment. , patients with moderate hepatic impairment should reduce the dose and use it under the guidance of a doctor. All patients should be closely monitored for liver function and adverse reactions during treatment.